Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Ammonia detoxification pathway encompasses coordinated enzymatic processes—primarily the hepatic urea cycle supplemented by extrahepatic glutamine synthesis—that convert potentially toxic free ammonia into non-toxic compounds suitable for elimination from the body. Dysfunction at any step may have serious clinical consequences including neurological impairment.
Ammonia scavengers bind to ammonia, forming compounds that are excreted in urine. Lactulose promotes ammonia excretion in feces. Rifaximin reduces ammonia-producing bacteria in the gut. Glycerol phenylbutyrate is converted to phenylacetate, which binds to glutamine and promotes its excretion.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia Detoxification Pathway.